2-(2-cresyl)-4h-1-3-2-benzodioxaphosphorin-2-oxide has been researched along with Seizures in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garrett, TL; Grubbs, RD; Lucot, JB; Rapp, CM; Schlager, JJ | 1 |
| Dettbarn, WD; Yang, ZP | 1 |
2 other study(ies) available for 2-(2-cresyl)-4h-1-3-2-benzodioxaphosphorin-2-oxide and Seizures
| Article | Year |
|---|---|
A murine model for sarin exposure using the carboxylesterase inhibitor CBDP.
Topics: Acetylcholinesterase; Animals; Carboxylesterase; Chemical Warfare Agents; Cholinesterases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Glial Fibrillary Acidic Protein; Hippocampus; Male; Mice; Mice, Inbred C57BL; Neuroglia; Neurotoxicity Syndromes; Organophosphorus Compounds; Sarin; Seizures; Time Factors | 2010 |
Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors.
Topics: Acetylcholinesterase; Animals; Brain; Butyrylcholinesterase; Carboxylesterase; Carboxylic Ester Hydrolases; Cholinesterase Inhibitors; Diarrhea; Drug Synergism; Drug Tolerance; Enzyme Inhibitors; Fasciculation; Kinetics; Male; Muscle, Skeletal; Organophosphorus Compounds; Paraoxon; Rats; Rats, Sprague-Dawley; Salivation; Seizures; Tetraisopropylpyrophosphamide; Tremor | 1998 |